BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7916993)

  • 1. Preferential primary-response gene expression in promotion-resistant versus promotion-sensitive JB6 cells.
    Cmarik JL; Herschman H; Colburn NH
    Mol Carcinog; 1994 Oct; 11(2):115-24. PubMed ID: 7916993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines.
    Lim IK; Lee MS; Lee SH; Kim NK; Jou I; Seo JS; Park SC
    J Cancer Res Clin Oncol; 1995; 121(5):279-84. PubMed ID: 7768965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
    Dong Z; Birrer MJ; Watts RG; Matrisian LM; Colburn NH
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):609-13. PubMed ID: 8290571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation.
    Ben-Ari ET; Bernstein LR; Colburn NH
    Mol Carcinog; 1992; 5(1):62-74. PubMed ID: 1543542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane and genetic events in tumor promotion: studies with promoter resistant variants of JB6 cells.
    Colburn NH; Lerman MI; Srinivas L; Nakamura Y; Gindhart TD
    Princess Takamatsu Symp; 1983; 14():155-66. PubMed ID: 6394588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential induction of primary-response (TIS) genes in PC12 pheochromocytoma cells and the unresponsive variant PC12nnr5.
    Altin JG; Kujubu DA; Raffioni S; Eveleth DD; Herschman HR; Bradshaw RA
    J Biol Chem; 1991 Mar; 266(9):5401-6. PubMed ID: 2005087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor promoters 12-O-tetradecanoylphorbol-13-acetate and okadaic acid differ in toxicity, mitogenic activity and induction of gene expression.
    Herschman HR; Lim RW; Brankow DW; Fujiki H
    Carcinogenesis; 1989 Aug; 10(8):1495-8. PubMed ID: 2752524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of primary response gene expression in skeletal muscle cells through multiple signal transduction pathways.
    Lim RW; Zhu CY; Stringer B
    Biochim Biophys Acta; 1995 Apr; 1266(1):91-100. PubMed ID: 7718627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells.
    Bernstein LR; Colburn NH
    Science; 1989 May; 244(4904):566-9. PubMed ID: 2541502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells.
    Nakamura Y; Gindhart TD; Winterstein D; Tomita I; Seed JL; Colburn NH
    Carcinogenesis; 1988 Feb; 9(2):203-7. PubMed ID: 2827903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
    Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
    Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies.
    Colburn NH; Wendel E; Srinivas L
    J Cell Biochem; 1982; 18(3):261-70. PubMed ID: 7068782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the antioxidative property of morusin in blocking phorbol ester-induced malignant transformation of JB6 P
    Cheng PS; Hu CC; Wang CJ; Lee YJ; Chung WC; Tseng TH
    Chem Biol Interact; 2017 Feb; 264():34-42. PubMed ID: 28108223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters.
    Fletcher BS; Lim RW; Varnum BC; Kujubu DA; Koski RA; Herschman HR
    J Biol Chem; 1991 Aug; 266(22):14511-8. PubMed ID: 1713584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells.
    Huang C; Ma WY; Young MR; Colburn N; Dong Z
    Proc Natl Acad Sci U S A; 1998 Jan; 95(1):156-61. PubMed ID: 9419345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary-response TIS genes in both proliferating and terminally differentiated myeloid cells.
    Varnum BC; Lim RW; Kujubu DA; Luner SJ; Kaufman SE; Greenberger JS; Gasson JC; Herschman HR
    Mol Cell Biol; 1989 Aug; 9(8):3580-3. PubMed ID: 2677677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta 1 augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in Swiss 3T3 cells and in murine embryo fibroblasts.
    Gilbert RS; Reddy ST; Kujubu DA; Xie W; Luner S; Herschman HR
    J Cell Physiol; 1994 Apr; 159(1):67-75. PubMed ID: 8138592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells.
    Cmarik JL; Li Y; Ogram SA; Min H; Reeves R; Colburn NH
    Oncogene; 1998 Jul; 16(26):3387-96. PubMed ID: 9692546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Macrophage" nitric oxide synthase is a glucocorticoid-inhibitable primary response gene in 3T3 cells.
    Gilbert RS; Herschman HR
    J Cell Physiol; 1993 Oct; 157(1):128-32. PubMed ID: 7691832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.